Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma
Clinical trial NCT01307605 · TERMINATED
Trial details
- NCT number
- NCT01307605
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-09
- Primary completion
- 2014-06-20
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.